Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel P Hermans

Showing results (41-50 of 122) with videos related to

Pageof 13
Sort By:
Cardiovascular Diabetology|March 2, 2011
Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalenceMichel P Hermans, Frank M Sacks, Sylvie A Ahn, et al.
Diabetes & Metabolic Syndrome|September 16, 2014
Novel determinants preventing achievement of major cardiovascular targets in type 2 diabetesSoumaïla Camara, Evariste Bouenizabila, Michel P Hermans, et al.
BMC Cardiovascular Disorders|April 19, 2015
Bioelectrical impedance outperforms waist circumference for predicting cardiometabolic risk in Congolese hypertensive subjects: a cross-sectional studyPhilippe Bianga Katchunga, Achile Mwira Bapolisi, Jean-René M'Buyamba-Kabangu, et al.
European Journal of Preventive Cardiology|May 19, 2012
Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countriesMichel P Hermans, Carlos Brotons, Moses Elisaf, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 14, 2016
Sflt-1 in heart failure: relation with disease severity and biomarkersDamien Gruson, Michel P Hermans, Benjamin Ferracin, et al.
Acta Clinica Belgica|April 1, 2017
An unusual cause of epidemic thyrotoxicosisLucie Wartique, Lucie Pothen, Nathalie Pirson, et al.
European Heart Journal. Case Reports|September 8, 2023
Unsuspected diabetic ketoacidosis after myocardial infarction in a patient treated with SGLT2 inhibitor increased length of stay in the hospital: how can it be prevented? A case reportPhilippe Oriot, Michel P Hermans, Christophe Beauloye, et al.
Journal of Endocrinological Investigation|May 17, 2025
Glycemia risk index (GRI): a metric designed to facilitate the interpretation of continuous glucose monitoring data: a narrative reviewPhilippe Oriot, Gaëtan Prévost, Jean-Christophe Philips, et al.
Blood Pressure. Supplement|January 6, 2010
Quality of life and efficacy of nebivolol in an open-label study in hypertensive patients. the QoLaN studyMichel P Hermans, Olivier De Coster, Laurence Seidel, et al.
Complementary Therapies in Medicine|November 21, 2017
Efficacy and safety of a combination of red yeast rice and olive extract in hypercholesterolemic patients with and without statin-associated myalgiaChristian Tshongo Muhindo, Sylvie A Ahn, Michel F Rousseau, et al.
Pageof 13

Showing results (41-50 of 122) with videos related to

Sort By:
Pageof 13
Cardiovascular Diabetology|March 2, 2011
Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalenceMichel P Hermans, Frank M Sacks, Sylvie A Ahn, et al.
Diabetes & Metabolic Syndrome|September 16, 2014
Novel determinants preventing achievement of major cardiovascular targets in type 2 diabetesSoumaïla Camara, Evariste Bouenizabila, Michel P Hermans, et al.
BMC Cardiovascular Disorders|April 19, 2015
Bioelectrical impedance outperforms waist circumference for predicting cardiometabolic risk in Congolese hypertensive subjects: a cross-sectional studyPhilippe Bianga Katchunga, Achile Mwira Bapolisi, Jean-René M'Buyamba-Kabangu, et al.
European Journal of Preventive Cardiology|May 19, 2012
Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countriesMichel P Hermans, Carlos Brotons, Moses Elisaf, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 14, 2016
Sflt-1 in heart failure: relation with disease severity and biomarkersDamien Gruson, Michel P Hermans, Benjamin Ferracin, et al.
Acta Clinica Belgica|April 1, 2017
An unusual cause of epidemic thyrotoxicosisLucie Wartique, Lucie Pothen, Nathalie Pirson, et al.
European Heart Journal. Case Reports|September 8, 2023
Unsuspected diabetic ketoacidosis after myocardial infarction in a patient treated with SGLT2 inhibitor increased length of stay in the hospital: how can it be prevented? A case reportPhilippe Oriot, Michel P Hermans, Christophe Beauloye, et al.
Journal of Endocrinological Investigation|May 17, 2025
Glycemia risk index (GRI): a metric designed to facilitate the interpretation of continuous glucose monitoring data: a narrative reviewPhilippe Oriot, Gaëtan Prévost, Jean-Christophe Philips, et al.
Blood Pressure. Supplement|January 6, 2010
Quality of life and efficacy of nebivolol in an open-label study in hypertensive patients. the QoLaN studyMichel P Hermans, Olivier De Coster, Laurence Seidel, et al.
Complementary Therapies in Medicine|November 21, 2017
Efficacy and safety of a combination of red yeast rice and olive extract in hypercholesterolemic patients with and without statin-associated myalgiaChristian Tshongo Muhindo, Sylvie A Ahn, Michel F Rousseau, et al.
Pageof 13